@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-ACES_SU-AS000237 a mbo:MassSpectrum ;
    dcterms:creator "ACESx, Jonathan W. Martin Group" ;
    dcterms:date "2022-08-15"^^xsd:date ;
    dcterms:identifier "MSBNK-ACES_SU-AS000237" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights "Stockholm University, ACESx, Jonathan W. Martin Group (C) 2022 under CC BY" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "QExactive Orbitrap HF-X (Thermo Scientific)" ;
            mbo:collision_energy "Ramp 20%-70% (nominal)" ;
            mbo:column_name "Waters; Acquity UPLC BEH C18, 2.1 x 100 mm, 1.7 um, Waters" ;
            mbo:flow_gradient "98/2 at 4.2 min, 0/100 at 22 min, 0/100 at 25 min, 98/2 at 25.1 min, 98/2 at 30 min" ;
            mbo:flow_rate "0.45mL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-ESI-QFT" ;
            mbo:ion_mode "NEGATIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "30000" ;
            mbo:retention_time "16.309200" ;
            mbo:solvent "A 1 mM ammonium fluoride in water",
                "B MeOH" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",
                "Clarithromycin" ;
            mbo:ch_compound_class "Drugs; Antiinfective Agents; Antibiotics; Macrolides" ;
            mbo:ch_exact_mass 7.474769e+02 ;
            schema:inChI "InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1" ;
            schema:molecularFormula "C38H69NO13" ;
            schema:name "(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",
                "Clarithromycin" ;
            schema:smiles "CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O" ] ;
    mbo:has_peak [ mbo:intensity 4.1797e+04 ;
            mbo:mz 1.290552e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 66 ],
        [ mbo:intensity 1.30159e+05 ;
            mbo:mz 6.324028e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 205 ],
        [ mbo:intensity 1.9966e+04 ;
            mbo:mz 7.28455e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 32 ],
        [ mbo:intensity 6.32749e+05 ;
            mbo:mz 7.464695e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.65578e+05 ;
            mbo:mz 1.741139e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 261 ],
        [ mbo:intensity 7.215e+04 ;
            mbo:mz 2.811734e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 114 ],
        [ mbo:intensity 2.1015e+04 ;
            mbo:mz 3.372019e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 33 ],
        [ mbo:intensity 2.2262e+04 ;
            mbo:mz 3.952452e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 35 ],
        [ mbo:intensity 1.92136e+05 ;
            mbo:mz 4.56298e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 303 ],
        [ mbo:intensity 1.4036e+04 ;
            mbo:mz 5.12324e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 22 ],
        [ mbo:intensity 1.6247e+04 ;
            mbo:mz 5.523586e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 26 ],
        [ mbo:intensity 7.8364e+04 ;
            mbo:mz 5.703667e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 124 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 7.464695e+02 ;
            mbo:precursor_mz 7.464703e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 12 ;
    mbo:pk_splash "splash10-0002-0200211900-a30117850198db18fb47" ;
    rdfs:comment "CONFIDENCE Standard Compound (Level 1)" ;
    skos:definition "Clarithromycin; LC-ESI-QFT; MS2; CE: Ramp 20%-70% (nominal); R=30000; [M-H]-" .

